NT5E/CD73+ CD4+ T cells might represent a novel memory-effector cell population, particularly enriched with Th-17+ cells, which could be used to monitor IBD activity during treatment (Doherty et al., 2012). Here, CD4 is linked to inflammatory bowel disease.